Recombinant multi-species CXCL11 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis
Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine CXCL11 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
Chemokines are a group of small (approximately 8 to 14 kD), mostly basic, structurally related molecules that regulate cell trafficking of various types of leukocytes through interactions with a subset of 7-transmembrane, G protein-coupled receptors. Chemokines also play fundamental roles in the development, homeostasis, and function of the immune system, and they have effects on cells of the central nervous system as well as on endothelial cells involved in angiogenesis or angiostasis. Chemokines are divided into 2 major subfamilies, CXC and CC. This antimicrobial gene is a CXC member of the chemokine superfamily. Its encoded protein induces a chemotactic response in activated T-cells and is the dominant ligand for CXC receptor-3. The gene encoding this protein contains 4 exons and at least three polyadenylation signals which might reflect cell-specific regulation of expression. IFN-gamma is a potent inducer of transcription of this gene. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Oct 2014]
The Alternative Names of target: Beta-R1,C-X-C motif chemokine 11,CXCL11,Cxcl11,H174,I-TAC,IP-9,IP9,Interferon gamma-inducible protein 9 (IP-9),Interferon-inducible T-cell alpha chemoattractant (I-TAC),SCYB11,SCYB9B,Small-inducible cytokine B11,b-R1
Go
to CXCL11 products collection
>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product information
| Catalog No. | Product Name | Species Reactivity |
|---|---|---|
| GM-Tg-hg-T68465-Ag-1/ GM-Tg-hg-T68465-Ag-2 | Human CXCL11 protein | Human |
| GM-Tg-rg-T68465-Ag-1/ GM-Tg-rg-T68465-Ag-2 | Rat CXCL11 protein | Rat |
| GM-Tg-mg-T68465-Ag-1/ GM-Tg-mg-T68465-Ag-2 | Mouse CXCL11 protein | Mouse |
| GM-Tg-cynog-T68465-Ag-1/ GM-Tg-cynog-T68465-Ag-2 | Cynomolgus/Rhesus macaque CXCL11 protein | Cynomolgus/ Rhesus macaque |
| GM-Tg-felg-T68465-Ag-1/ GM-Tg-felg-T68465-Ag-2 | Feline CXCL11 protein | Feline |
| GM-Tg-cang-T68465-Ag-1/ GM-Tg-cang-T68465-Ag-2 | Canine CXCL11 protein | Canine |
| GM-Tg-bovg-T68465-Ag-1/ GM-Tg-bovg-T68465-Ag-2 | Bovine CXCL11 protein | Bovine |
| GM-Tg-equg-T68465-Ag-1/ GM-Tg-equg-T68465-Ag-2 | Equine CXCL11 protein | Equine |
Size: 1mg | 10mg | 100mg
Product Description
| Catalog No. |
GM-Tg-hg-T68465-Ag-1/ GM-Tg-hg-T68465-Ag-2;
GM-Tg-rg-T68465-Ag-1/ GM-Tg-rg-T68465-Ag-2;
GM-Tg-mg-T68465-Ag-1/ GM-Tg-mg-T68465-Ag-2; GM-Tg-cynog-T68465-Ag-1/ GM-Tg-cynog-T68465-Ag-2; GM-Tg-felg-T68465-Ag-1/ GM-Tg-felg-T68465-Ag-2; GM-Tg-cang-T68465-Ag-1/ GM-Tg-cang-T68465-Ag-2; GM-Tg-bovg-T68465-Ag-1/ GM-Tg-bovg-T68465-Ag-2; GM-Tg-equg-T68465-Ag-1/ GM-Tg-equg-T68465-Ag-2 |
| Products Name | CXCL11 protein |
| Species | Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine |
| Target Name | CXCL11 |
| Protein Sub-location | Secreted Protein/Potential Cytokines |
| Isotypes | Recombinant protein |
| Expression platform | Mammalian cell |
| Bioactivity validation | Affintiy&bioactivity validated by ELISA, cell culture validated. |
| Tag | His |
| Products description | Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine CXCL11 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic). |
| Purity | Purity: ≥95% (SDS-PAGE) |
| Application | In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
| Formulation & Reconstitution |
Lyophilized from GM's Protein Stability Buffer2
(PSB2,Confidential Ingredients) or PBS
(pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
| Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
About Gmab

GMab, developed by GeneMedi, constitutes an
advanced library of recombinant
monoclonal antibodies, each meticulously
designed to target specific molecular
entities. Leveraging the sophisticated
capabilities of GM’s Taurus™ and LIBRA™
platforms, GMab synthesizes antibodies
characterized by high binding affinity,
exceptional physicochemical stability, and
optimal developability profiles.
Through
expression in mammalian cell lines, GMab has
been established as a paradigmatic
reference antibody. It holds significance in
myriad domains of biological drug
discovery, encompassing cellular cultivation,
innovative assay methodologies,
strategic animal model systematization, in-depth
pharmacokinetic & pharmacodynamic
(PK/PD) modeling, and intricate mechanism of
action (MOA) investigations.